{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:34:06Z","timestamp":1793644446893,"version":"4.5.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.colsurfb.2023.113567","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T21:16:52Z","timestamp":1695849412000},"page":"113567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy"],"prefix":"10.1016","volume":"231","author":[{"given":"Kaili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.colsurfb.2023.113567_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.colsurfb.2023.113567_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastrotroenterol. Hepatol."},{"key":"10.1016\/j.colsurfb.2023.113567_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2023.113567_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biopha.2017.01.107","article-title":"Sorafenib: a potential therapeutic drug for hepatic fibrosis and its outcomes","volume":"88","author":"Ma","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.colsurfb.2023.113567_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats","volume":"26","author":"Boigk","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.colsurfb.2023.113567_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1478-3231.2007.01452.x","article-title":"Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model","volume":"27","author":"Luk","year":"2007","journal-title":"Liver Int."},{"issue":"15\u201316","key":"10.1016\/j.colsurfb.2023.113567_bib7","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.lfs.2008.07.023","article-title":"Glycyrrhizin and its metabolite inhibit Smad3-mediated type I collagen gene transcription and suppress experimental murine liver fibrosis","volume":"83","author":"Moro","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.colsurfb.2023.113567_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.874408","article-title":"New drugs for hepatic fibrosis","volume":"13","author":"Shan","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.colsurfb.2023.113567_bib9","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0168-8278(02)00245-3","article-title":"Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production","volume":"37","author":"Di Sario","year":"2002","journal-title":"J. Hepatol."},{"issue":"36","key":"10.1016\/j.colsurfb.2023.113567_bib10","doi-asserted-by":"crossref","first-page":"9241","DOI":"10.1126\/sciadv.abg9241","article-title":"The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1","volume":"7","author":"Xi","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.colsurfb.2023.113567_bib11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.2147\/IJN.S171280","article-title":"CXCR4-targeted liposomal mediated co-delivery of pirfenidone and AMD3100 for the treatment of TGF\u03b2-induced HSC-T6 cells activation","volume":"14","author":"Ullah","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"8","key":"10.1016\/j.colsurfb.2023.113567_bib12","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3390\/biomedicines9081014","article-title":"Extra- and intra-cellular mechanisms of hepatic stellate cell activation","volume":"9","author":"Yan","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.colsurfb.2023.113567_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122134","article-title":"Retinol-binding protein-hijacking nanopolyplex delivering siRNA to cytoplasm of hepatic stellate cell for liver fibrosis alleviation","volume":"299","author":"Huang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2023.113567_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2022.01.038","article-title":"Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis","volume":"343","author":"Zhou","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2023.113567_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154721","article-title":"Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: an update","volume":"113","author":"Zheng","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.colsurfb.2023.113567_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119473","article-title":"Hyaluronic acid-targeted and pH-responsive drug delivery system based on metal-organic frameworks for efficient antitumor therapy","volume":"223","author":"Sun","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2023.113567_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121503","article-title":"ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy","volume":"284","author":"Yu","year":"2022","journal-title":"Biomaterials"},{"issue":"45","key":"10.1016\/j.colsurfb.2023.113567_bib18","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1002\/anie.202210487","article-title":"An ion-enhanced oncolytic virus-like nanoparticle for tumor immunotherapy","volume":"61","author":"Wu","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.colsurfb.2023.113567_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.colsurfb.2023.113567_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"B\u00f6ttcher","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.colsurfb.2023.113567_bib21","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2023.113567_bib22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejps.2013.11.017","article-title":"Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats","volume":"52","author":"Yang","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2023.113567_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2021.11.033","article-title":"Sequential delivery for hepatic fibrosis treatment based on carvedilol loaded star-like nanozyme","volume":"341","author":"Lu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2023.113567_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117964","article-title":"Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.colsurfb.2023.113567_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jgh.1998.13.s1.19","article-title":"Molecular mechanisms in the reversible regulation of morphology, proliferation and collagen metabolism in hepatic stellate cells by the three-dimensional structure of the extracellular matrix","volume":"13","author":"Senoo","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.colsurfb.2023.113567_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.colsurfb.2023.113567_bib27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/advs.201801809","article-title":"Synergistic MicroRNA therapy in liver fibrotic rat using MRI-visible nanocarrier targeting hepatic stellate cells","volume":"6","author":"Wu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2023.113567_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2021.06.031","article-title":"Vitamin A-coupled stem cell-derived extracellular vesicles regulate the fibrotic cascade by targeting activated hepatic stellate cells in vivo","volume":"336","author":"You","year":"2021","journal-title":"J. Control. Release"},{"issue":"23","key":"10.1016\/j.colsurfb.2023.113567_bib29","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1039\/C9CS00472F","article-title":"Colloidal metal-organic framework particles: the pioneering case of ZIF-8","volume":"48","author":"Troyano","year":"2019","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.colsurfb.2023.113567_bib30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/jacs.5b11720","article-title":"One-pot synthesis of metal-organic frameworks with encapsulated target molecules and their applications for controlled drug delivery","volume":"138","author":"Zheng","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.colsurfb.2023.113567_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.colsurfb.2017.06.029","article-title":"Polysaccharide-coated liposomes by post-insertion of a hyaluronan-lipid conjugate","volume":"158","author":"Cosco","year":"2017","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.colsurfb.2023.113567_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120711","article-title":"Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA\/Resveratrol with dual-responsive polyplexes","volume":"271","author":"Jia","year":"2021","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.colsurfb.2023.113567_bib33","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/acsbiomaterials.0c00231","article-title":"HA-modified R8-based bola-amphiphile nanocomplexes for effective improvement of siRNA delivery efficiency","volume":"6","author":"Jia","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.colsurfb.2023.113567_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.biomaterials.2018.02.022","article-title":"Biocompatible and biodegradable zeolitic imidazolate framework\/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy","volume":"162","author":"Wu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2023.113567_bib35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2022.08.065","article-title":"Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy","volume":"152","author":"Zhou","year":"2022","journal-title":"Acta Biomater."},{"issue":"3727","key":"10.1016\/j.colsurfb.2023.113567_bib36","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.152.3727.1335","article-title":"Formation of hydroxyproline in collagen","volume":"152","author":"Udenfriend","year":"1966","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.colsurfb.2023.113567_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201903138","article-title":"Nanodrug with ROS and pH dual-sensitivity ameliorates liver fibrosis via multicellular regulation","volume":"7","author":"Lin","year":"2020","journal-title":"Adv. Sci."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776523004459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776523004459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:25:31Z","timestamp":1760527531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776523004459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"alternative-id":["S0927776523004459"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113567","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2023.113567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113567"}}